Table of Contents Author Guidelines Submit a Manuscript
Autism Research and Treatment
Volume 2011 (2011), Article ID 307152, 8 pages
http://dx.doi.org/10.1155/2011/307152
Research Article

Developing a Deeper Understanding of Autism: Connecting Knowledge through Literature Mining

1Department of Child Neurology, University Pediatric Hospital Ljubljana, Bohoričeva 20, 1000 Ljubljana, Slovenia
2Centre for Systems and Information Technologies, University of Nova Gorica, Vipavska 13, 5000 Nova Gorica, Slovenia
3Department of Knowledge Technologies, Jozef Stefan Institute, Jamova 39, 1000 Ljubljana, Slovenia

Received 9 February 2011; Accepted 13 April 2011

Academic Editor: Mohammad Ghaziuddin

Copyright © 2011 Marta Macedoni-Lukšič et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Centers for Disease Control and Prevention (CDC), “Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, United States, 2006. Autism and developmental disabilities monitoring network surveillance year 2006 principal investigators,” MMWR Surveillance Summaries, vol. 58, no. 10, pp. 1–20, Erratum in: MMWR Surveillance Summaries, vol. 58, no. 30, pp. 956.
  2. S. Bent and R. L. Hendren, “Improving the prediction of response to therapy in autism,” Neurotherapeutics, vol. 7, no. 3, pp. 232–240, 2010. View at Publisher · View at Google Scholar · View at PubMed
  3. M. Careaga, J. van de Water, and P. Ashwood, “Immune dysfunction in autism: a pathway to treatment,” Neurotherapeutics, vol. 7, no. 3, pp. 283–292, 2010. View at Publisher · View at Google Scholar · View at PubMed
  4. R. J. Hagerman and R. L. Hendren, “Shifting the paradigm for autism treatments,” Neurotherapeutics, vol. 7, no. 3, pp. 230–231, 2010. View at Publisher · View at Google Scholar · View at PubMed
  5. M. G. Chez and N. Guido-Estrada, “Immune therapy in autism: historical experience and future directions with immunomodulatory therapy,” Neurotherapeutics, vol. 7, no. 3, pp. 293–301, 2010. View at Publisher · View at Google Scholar · View at PubMed
  6. D. B. Campbell, J. S. Sutcliffe, P. J. Ebert et al., “A genetic variant that disrupts MET transcription is associated with autism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 45, pp. 16834–16839, 2006. View at Publisher · View at Google Scholar · View at PubMed
  7. D. R. Swanson, “Medical literature as a potential source of new knowledge,” Bulletin of the Medical Library Association, vol. 78, no. 1, pp. 29–37, 1990. View at Google Scholar
  8. M. Weeber, R. Vos, H. Klein, and T. W. De Jong-van den Berg, “Using concepts in literature-based discovery: simulating swanson’s Raynaud–fish oil and migraine–magnesium discoveries,” Journal of the American Society for Information Science and Technology, vol. 52, no. 7, pp. 548–557, 2001. View at Publisher · View at Google Scholar
  9. M. Weeber, R. Vos, H. Klein, L. T. W. De Jong-Van Den Berg, A. R. Aronson, and G. Molema, “Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide,” Journal of the American Medical Informatics Association, vol. 10, no. 3, pp. 252–259, 2003. View at Publisher · View at Google Scholar · View at PubMed
  10. I. Petrič, T. Urbančič, and B. Cestnik, “Discovering hidden knowledge from biomedical literature,” Informatica, vol. 31, no. 1, pp. 15–20, 2007. View at Google Scholar
  11. T. Urbančič, I. Petrič, B. Cestnik, and M. Macedoni-Lukšič, “Literature mining: towards better understanding of autism,” in Proceedings of the 11th Conference on Artificial Intelligence in Medicine in Europe, R. Bellazzi, A. Abu-Hanna, and J. Hunter, Eds., vol. 4594, pp. 217–226, Amsterdam, The Netherlands, 2007.
  12. I. Petrič, T. Urbančič, B. Cestnik, and M. Macedoni-Lukšič, “Literature mining method RaJoLink for uncovering relations between biomedical concepts,” Journal of Biomedical Informatics, vol. 42, no. 2, pp. 219–227, 2009. View at Publisher · View at Google Scholar · View at PubMed
  13. B. Fortuna, M. Grobelnik, and D. Mladenić, “Background knowledge for ontology construction,” in Proceedings of the 3rd European Semantic Web Conference (ESCW '06), pp. 949–950, Demo, Budva, Montenegro, 2006. View at Publisher · View at Google Scholar
  14. K. M. Huber, S. M. Gallagher, S. T. Warren, and M. F. Bear, “Altered synaptic plasticity in a mouse model of fragile X mental retardation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 11, pp. 7746–7750, 2002. View at Publisher · View at Google Scholar · View at PubMed
  15. R. J. Hagerman, “The physical and behavioural phenotype,” in Fragile X Syndrome, R. J. Hagerman and P. J. Hagerman, Eds., pp. 58–63, The Johns Hopkins University Press, Baltimore, Md, USA, 2002. View at Google Scholar
  16. C. B. Klee, T. H. Crouch, and M. H. Krinks, “Calcineurin: a calcium- and calmodulin-binding protein of the nervous system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 12, pp. 6270–6273, 1979. View at Google Scholar
  17. J. I. Lee and J. Ahnn, “Calcineurin in animal behavior,” Molecules and Cells, vol. 17, no. 3, pp. 390–396, 2004. View at Google Scholar
  18. T. Miyakawa, L. M. Leiter, D. J. Gerber et al., “Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 15, pp. 8987–8992, 2003. View at Publisher · View at Google Scholar · View at PubMed
  19. D. H. Geschwind and P. Levitt, “Autism spectrum disorders: developmental disconnection syndromes,” Current Opinion in Neurobiology, vol. 17, no. 1, pp. 103–111, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. P. Jin, R. S. Alisch, and S. T. Warren, “RNA and microRNAs in fragile X mental retardation,” Nature Cell Biology, vol. 6, no. 11, pp. 1048–1053, 2004. View at Publisher · View at Google Scholar · View at PubMed
  21. C. D'Hulst and R. F. Kooy, “Fragile X syndrome: from molecular genetics to therapy,” Journal of Medical Genetics, vol. 46, no. 9, pp. 577–584, 2009. View at Publisher · View at Google Scholar · View at PubMed
  22. A. Citri and R. C. Malenka, “Synaptic plasticity: multiple forms, functions, and mechanisms,” Neuropsychopharmacology, vol. 33, no. 1, pp. 18–41, 2008. View at Publisher · View at Google Scholar · View at PubMed
  23. S. K. Koekkoek, K. Yamaguchi, B. A. Milojkovic et al., “Deletion of FMR1 in purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in fragile X syndrome,” Neuron, vol. 4, no. 3, pp. 339–352, 2005. View at Publisher · View at Google Scholar · View at PubMed
  24. M. F. Bear, K. M. Huber, and S. T. Warren, “The mGluR theory of fragile X mental retardation,” Trends in Neurosciences, vol. 27, no. 7, pp. 370–377, 2004. View at Publisher · View at Google Scholar · View at PubMed
  25. Y. L. Liu, C. S. Fann, C. M. Liu et al., “More evidence supports the association of PPP3CC with schizophrenia,” Molecular Psychiatry, vol. 12, no. 10, pp. 966–974, 2007. View at Publisher · View at Google Scholar · View at PubMed
  26. R. Sen and D. Baltimore, “Multiple nuclear factors interact with the immunoglobulin enhancer sequences,” Cell, vol. 46, no. 5, pp. 705–716, 1986. View at Google Scholar
  27. A. Gross, J. M. McDonnell, and S. J. Korsmeyer, “BCL-2 family members and the mitochondria in apoptosis,” Genes and Development, vol. 13, no. 15, pp. 1899–1911, 1999. View at Google Scholar
  28. S. H. Fatemi, J. M. Stary, A. R. Halt, and G. R. Realmuto, “Dysregulation of reelin and Bcl-2 Proteins in autistic cerebellum,” Journal of Autism and Developmental Disorders, vol. 31, no. 6, pp. 529–535, 2001. View at Publisher · View at Google Scholar
  29. M. P. Mattson, “NF-κB in the survival and plasticity of neurons,” Neurochemical Research, vol. 30, no. 6-7, pp. 883–893, 2005. View at Publisher · View at Google Scholar · View at PubMed
  30. N. Erin, S. K. Bronson, and M. L. Billingsley, “Calcium-dependent interaction of calcineurin with Bcl-2 in neuronal tissue,” Neuroscience, vol. 117, no. 3, pp. 541–555, 2003. View at Publisher · View at Google Scholar
  31. Y. J. Lee, J. C. Chen, A. A. Amoscato et al., “Protective role in Bcl2 in metabolic oxidative stress-induced cell death,” Journal of Cell Science, vol. 114, no. 4, pp. 677–684, 2001. View at Google Scholar
  32. A. Chauhan and V. Chauhan, “Oxidative stress in autism,” Pathophysiology, vol. 13, no. 3, pp. 171–181, 2006. View at Publisher · View at Google Scholar · View at PubMed
  33. D. A. Rossignol and R. E. Frye, “Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis,” Molecular Psychiatry, pp. 1–25, 2011. View at Publisher · View at Google Scholar · View at PubMed
  34. G. Oliveira, L. Diogo, P. Grazina et al., “Mitochondrial dysfunction in autism spectrum disorders: a population-based study,” Developmental Medicine and Child Neurology, vol. 47, no. 3, pp. 185–189, 2005. View at Publisher · View at Google Scholar
  35. S. J. Jeon, J. E. Seo, S. Yang et al., “Cellular stress-induced up-regulation of FMRP promotes cell survival by modulating PI3K-Akt phosphorylation cascades,” Journal of Biomedical Science, vol. 18, no. 1, pp. 17–32, 2011. View at Publisher · View at Google Scholar · View at PubMed
  36. X. Li, A. Chauhan, A. M. Sheikh et al., “Elevated immune response in the brain of autistic patients,” Journal of Neuroimmunology, vol. 15, no. 1-2, pp. 111–116, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. D. L. Vargas, C. Nascimbene, C. Krishnan, A. W. Zimmerman, and C. A. Pardo, “Neuroglial activation and neuroinflammation in the brain of patients with autism,” Annals of Neurology, vol. 57, no. 1, pp. 67–81, 2005. View at Publisher · View at Google Scholar · View at PubMed
  38. A. C. Pardo, “Immunity, neuroglia and neuroinflammation in autism,” International Review of Psychiatry, vol. 17, no. 6, pp. 485–495, 2005. View at Publisher · View at Google Scholar · View at PubMed
  39. P. G. Thomas, M. R. Carter, A. A. Da'dara, T. M. DeSimone, and D. A. Harn, “A helminth glycan induces APC maturation via alternative NF-κ B activation independent of I kappa B alpha degradation,” The Journal of Immunology, vol. 175, no. 4, pp. 2082–2090, 2005. View at Google Scholar
  40. K. S. Ahn and B. B. Aggarwal, “Transcription factor NF-{κ}B: a sensor for smoke and stress signals,” Annals of the New York Academy of Sciences, vol. 1056, pp. 218–233, 2005. View at Publisher · View at Google Scholar · View at PubMed
  41. I. Thibeault, N. Laflamme, and S. Rivest, “Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating lps and proinflammatory cytokines,” Journal of Comparative Neurology, vol. 434, no. 4, pp. 461–477, 2001. View at Publisher · View at Google Scholar
  42. C. Paribello, L. Tao, A. Folino et al., “Open-label add-on treatment trial of minocycline in fragile X syndrome,” BMC Neurology, vol. 10, pp. 91–100, 2010. View at Publisher · View at Google Scholar · View at PubMed
  43. J. Liu, J. D. Farmer Jr., W. S. Lane, J. Friedman, I. Weissman, and S. L. Schreiber, “Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes,” Cell, vol. 66, no. 4, pp. 807–815, 1991. View at Publisher · View at Google Scholar
  44. W. J. Steinbach, J. L. Reedy, R. A. Cramer Jr., J. R. Perfect, and J. Heitman, “Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections,” Nature Reviews Microbiology, vol. 5, no. 6, pp. 418–430, 2007. View at Publisher · View at Google Scholar · View at PubMed
  45. M. K. Belmonte, G. Allen, A. Beckel-Mitchener, L. M. Boulanger, R. A. Carper, and S. J. Webb, “Autism and abnormal development of brain connectivity,” Journal of Neuroscience, vol. 27, no. 42, pp. 9228–9231, 2004. View at Publisher · View at Google Scholar · View at PubMed
  46. X. Ming, T. P. Stein, M. Brimacombe, W. G. Johnson, G. H. Lambert, and G. C. Wagner, “Increased excretion of a lipid peroxidation biomarker in autism,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 73, no. 5, pp. 379–384, 2005. View at Publisher · View at Google Scholar · View at PubMed
  47. R. Roesler, J. A. Henriques, and G. Schwartsmann, “Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders,” CNS and Neurological Disorders—Drug Targets, vol. 5, no. 2, pp. 197–204, 2006. View at Publisher · View at Google Scholar
  48. R. S. Corral, M. A. Iniguez, J. Duque, R. Lopez-Perez, and M. Fresno, “Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells,” Oncogene, vol. 26, no. 7, pp. 958–969, 2007. View at Publisher · View at Google Scholar · View at PubMed
  49. D. G. Winder and J. D. Sweatt, “Roles of serine/threonine phosphatases in hippocampal synaptic plasticity,” Nature Reviews Neuroscience, vol. 2, no. 7, pp. 461–474, 2001. View at Publisher · View at Google Scholar · View at PubMed
  50. H. Chen, S. Polo, P. P. Di Fiore, and P. V. De Camilli, “Rapid Ca2+-dependent decrease of protein ubiquitination at synapses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 14908–14913, 2003. View at Publisher · View at Google Scholar · View at PubMed
  51. J. A. Vorstman, M. E. Morcus, S. N. Duijff et al., “The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 45, no. 9, pp. 1104–1113, 2006. View at Publisher · View at Google Scholar · View at PubMed
  52. S. Sivagnanasundaram, D. Fletcher, M. Hubank, E. Illingworth, D. Skuse, and P. Scambler, “Differential gene expression in the hippocampus of the Df1/+ mice: a model for 22q11.2 deletion syndrome and schizophrenia,” Brain Research, vol. 1139, no. 1, pp. 48–59, 2007. View at Publisher · View at Google Scholar · View at PubMed
  53. S. E. Mouridsen, B. Rich, T. Isager, and N. J. Nedergaard, “Autoimmune diseases in parents of children with infantile autism: a case-control study,” Developmental Medicine and Child Neurology, vol. 49, no. 6, pp. 429–432, 2007. View at Publisher · View at Google Scholar · View at PubMed
  54. W. E. Winter and D. Schatz, “Prevention strategies for type 1 diabetes mellitus: current status and future directions,” BioDrugs, vol. 17, no. 1, pp. 39–64, 2003. View at Publisher · View at Google Scholar
  55. G. C. Román, “Autism: transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents,” Journal of the Neurological Sciences, vol. 262, no. 1-2, pp. 15–26, 2007. View at Publisher · View at Google Scholar · View at PubMed
  56. A. K. Sinha, M. R. Pickard, M. J. Hubank et al., “Maternal hypothyroxinemia and brain development: II. Biochemical, metabolic and behavioural correlates,” Acta Medica Austriaca, vol. 19, supplement 1, pp. 49–54, 1992. View at Google Scholar
  57. Y. Omura, “Asbestos as a possible major cause of malignant lung tumors (including small cell carcinoma, adenocarcinoma & mesothelioma), brain tumors (i.e. astrocytoma & glioblastoma multiforme), many other malignant tumors, intractable pain including fibromyalgia, & some cardio-vascular pathology: safe & effective methods of reducing asbestos from normal & pathological areas,” Acupuncture and Electro-Therapeutics Research, vol. 31, no. 1-2, pp. 61–125, 2006. View at Google Scholar
  58. J. Li, B. Huang, X. Shi, V. Castranova, V. Vallyathan, and C. Huang, “Involvement of hydrogen peroxide in asbestos-induced NFAT activation,” Molecular and Cellular Biochemistry, vol. 234-235, pp. 161–168, 2002. View at Publisher · View at Google Scholar
  59. I. M. Thornton, “Out of time: a possible link between mirror neurons, autism and electromagnetic radiation,” Medical Hypotheses, vol. 67, no. 2, pp. 378–382, 2006. View at Publisher · View at Google Scholar · View at PubMed
  60. P. K. Manikonda, P. Rajendra, D. Devendranath et al., “Influence of extremely low frequency magnetic fields on Ca2+ signaling and NMDA receptor functions in rat hippocampus,” Neuroscience Letters, vol. 413, no. 2, pp. 145–149, 2007. View at Publisher · View at Google Scholar · View at PubMed
  61. L. Barnard, K. Muldoon, R. Hasan, G. O'Brien, and M. Stewart, “Profiling executive dysfunction in adults with autism and comorbid learning disability,” Autism, vol. 12, no. 2, pp. 125–141, 2008. View at Publisher · View at Google Scholar · View at PubMed
  62. J. D. Runyan, A. N. Moore, and P. K. Dash, “A role for prefrontal calcium-sensitive protein phosphatase and kinase activities in working memory,” Learning and Memory, vol. 12, no. 2, pp. 103–110, 2005. View at Publisher · View at Google Scholar · View at PubMed
  63. M. Araghi-Niknam and S. H. Fatemi, “Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects,” Cellular and Molecular Neurobiology, vol. 23, no. 6, pp. 945–952, 2003. View at Publisher · View at Google Scholar
  64. J. Zou and F. Crews, “CREB and NF-kappaB transcription factors regulate sensitivity to excitotoxic and oxidative stress induced neuronal cell death,” Cellular and Molecular Neurobiology, vol. 26, no. 4–6, pp. 385–405, 2006. View at Google Scholar
  65. H. J. Yoo, I. H. Cho, M. Park et al., “Association between PTGS2 polymorphism and autism spectrum disorders in Korean trios,” Neuroscience Research, vol. 62, no. 1, pp. 66–69, 2008. View at Publisher · View at Google Scholar · View at PubMed
  66. K. M. Lee, B. S. Kang, H. L. Lee et al., “Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity,” European Journal of Neuroscience, vol. 19, no. 12, pp. 3375–3381, 2004. View at Publisher · View at Google Scholar · View at PubMed
  67. D. Q. Ma, M. L. Cuccaro, J. M. Jaworski et al., “Dissecting the locus heterogeneity of autism: significant linkage to chromosome 12q14,” Molecular Psychiatry, vol. 12, no. 4, pp. 376–384, 2007. View at Publisher · View at Google Scholar · View at PubMed
  68. R. K. Weersma, L. E. Oostenbrug, I. M. Nolte et al., “Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases,” Scandinavian Journal of Gastroenterology, vol. 42, no. 7, pp. 827–833, 2007. View at Publisher · View at Google Scholar · View at PubMed
  69. S. D. Steele, N. J. Minshew, B. Luna, and J. A. Sweeney, “Spatial working memory deficits in autism,” Journal of Autism and Developmental Disorders, vol. 37, no. 4, pp. 605–612, 2007. View at Publisher · View at Google Scholar · View at PubMed
  70. S. Denis-Donini, A. Dellarole, P. Crociara et al., “Impaired adult neurogenesis associated with short-term memory defects in NF-κB p50-deficient mice,” Journal of Neuroscience, vol. 28, no. 15, pp. 3911–3919, 2008. View at Publisher · View at Google Scholar · View at PubMed
  71. H. Jyonouchi, L. Geng, A. Ruby, and B. Zimmerman-Bier, “Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention,” Neuropsychobiology, vol. 51, no. 2, pp. 77–85, 2005. View at Publisher · View at Google Scholar · View at PubMed
  72. E. L. Grigorenko, S. S. Han, C. M. Yrigollen et al., “Macrophage migration inhibitory factor and autism spectrum disorders,” Pediatrics, vol. 122, no. 2, pp. e438–e445, 2008. View at Publisher · View at Google Scholar · View at PubMed
  73. Y. Gore, D. Starlets, N. Maharshak et al., “Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex,” Journal of Biological Chemistry, vol. 283, no. 5, pp. 2784–2792, 2008. View at Publisher · View at Google Scholar · View at PubMed
  74. K. P. Johnson and B. A. Malow, “Sleep in children with autism spectrum disorders,” Current Treatment Options in Neurology, vol. 10, no. 5, pp. 350–359, 2008. View at Publisher · View at Google Scholar
  75. M. Yamauchi, S. Tamaki, K. Tomoda et al., “Evidence for activation of nuclear factor kappaB in obstructive sleep apnea,” Sleep and Breathing, vol. 10, no. 4, pp. 189–193, 2006. View at Publisher · View at Google Scholar · View at PubMed